Typically, the first effects you will notice wont necessarily be dramatic drops on the scale, but rather subtle changes like feeling fuller for longer, reduced appetite, and more control over cravings
During Ozempic clinical trials for type 2 diabetes treatment, constipation was a side effect reported by 3% to 5% of participants
Liraglutide (Saxenda) a GLP-1 receptor agonist licensed for weight management, with a more modest but clinically meaningful effect on body weight
Semaglutide activates GLP-1 receptors in the brain to reduce hunger signals and increase feelings of fullness, slows gastric emptying to prolong satiety, and improves insulin sensitivity and blood sugar regulation
Omega-3Essential fatty acids that support heart and brain health
He noted that GLP-1 is produced by enteroendocrine cells called L-cells, both in the small intestine and the colon